MYC and Burkitt lymphoma: Its human cellular homolog, MYC, was identified in Burkitt lymphoma (BL) patients with t(8;14)(q24;q32), in which MYC is translocated to the immunoglobulin heavy-chain (IGH) promoter and subsequently overexpressed [3].